Advantame

Advantame is a synthetic high-intensity sweetener structurally derived from aspartame, with an additional substituent that makes it approximately 20,000 times sweeter than sucrose — roughly 100 times more potent than aspartame itself. Unlike aspartame, it does not release phenylalanine upon metabolism, making it safe for individuals with phenylketonuria (PKU) without requiring a warning label. It is used at microscopic concentrations in beverages, dairy products, baked goods, and confectionery.

JECFA evaluated advantame in 2011 and established an ADI of 5 mg per kilogram of body weight per day. For a 70 kg adult this equates to 350 mg per day — an amount impossible to approach through realistic food consumption given the extraordinary sweetness potency involved. Comprehensive pre-approval toxicological, carcinogenicity, and reproductive studies showed no adverse effects at relevant doses.

Advantame is approved in the EU (E969), the United States (since 2014), Australia, and several other markets. It is one of the newer high-intensity sweeteners with a thorough pre-approval safety dossier. No post-approval safety signals have emerged since its commercial introduction. Unlike aspartame, no PKU warning is required. For consumers seeking a well-studied sweetener at minimal intake, advantame represents a strong safety profile among artificial sweeteners.